In this study, we used the human hepatocyte cell line HepG2 as a model for NASH and treated these cells with FFA to induce steatosis, followed by treatment with TNFα to mimic the inflammatory processes within the liver. This evidence concerns the gene TNF and metabolic dysfunction-associated steatohepatitis.